| Novel and reported pathogenic variants in exon 11 of BRCA2 gene in a cohort of Sri Lankan young breast cancer patients |
|
|
|
|
|
|
|
|
|
| Identification of MSH2 inversion of exons 1–7 in clinical evaluation of families with suspected Lynch syndrome |
|
|
|
|
|
|
|
|
|
| ATM mutations for surgeons |
|
|
|
|
|
|
|
|
|
| Embryonal rhabdomyosarcoma in a patient with a heterozygous frameshift variant in the DICER1 gene and additional manifestations of the DICER1 syndrome |
|
|
|
|
|
|
|
|
|
| Four generations of SDHB-related disease: complexities in management |
|
|
|
|
|
|
|
|
|
| Outcomes of retesting BRCA negative patients using multigene panels |
|
|
|
|
|
|
|
|
|
| Recurrent TP53 missense mutation in cancer patients of Arab descent |
|
|
|
|
|
|
✓ |
|
Arab descent |
| The hereditary nature of small cell carcinoma of the ovary, hypercalcemic type: two new familial cases |
|
|
|
|
|
|
|
|
|
| Truncation of the MSH2 C-terminal 60 amino acids disrupts effective DNA mismatch repair and is causative for Lynch syndrome |
|
|
|
|
|
|
|
|
|
| All in the family? Analyzing the impact of family history in addition to genotype on medullary thyroid carcinoma aggressiveness in MEN2A patients |
|
|
|
|
|
|
|
|
|
| Detection of false positive mutations in BRCA gene by next generation sequencing |
|
|
|
|
|
|
|
|
|
| Double germline mutations in APC and BRCA2 in an individual with a pancreatic tumor |
|
|
|
|
|
|
|
|
|
| Identification of a rare germline NBN gene mutation by whole exome sequencing in a lung-cancer survivor from a large family with various types of cancer |
|
|
|
|
|
|
|
|
|
| Analysis of a RECQL splicing mutation, c.1667_1667+3delAGTA, in breast cancer patients and controls from Central Europe |
|
|
|
|
|
|
|
|
|
| Cancer screening behaviors and risk perceptions among family members of colorectal cancer patients with unexplained mismatch repair deficiency |
|
|
|
|
|
|
|
|
|
| DICER1 mutation and tumors associated with a familial tumor predisposition syndrome: practical considerations |
|
|
|
|
|
|
|
|
|
| Colonoscopy in Lynch syndrome: the need for a new quality score |
|
|
|
|
|
|
|
|
|
| Uptake of prenatal diagnostic testing for retinoblastoma compared to other hereditary cancer syndromes in the Netherlands |
|
|
|
|
|
|
|
|
|
| Uptake of genetic counseling, genetic testing and surveillance in hereditary malignant melanoma (CDKN2A) in Norway |
|
|
|
|
|
|
|
|
|
| Risk algorithms that include pathology adjustment for HER2 amplification need to make further downward adjustments in likelihood scores |
|
|
|
|
|
|
|
|
|
| Pain evaluation during gynaecological surveillance in women with Lynch syndrome |
|
|
|
|
|
|
|
|
|
| Attenuated polyposis of the large bowel: a morphologic and molecular approach |
|
|
|
|
|
|
|
|
|
| BRCA1 allele-specific expression in genetic predisposed breast/ovarian cancer |
|
|
|
|
|
|
|
|
|
| A case of multiple gastrointestinal stromal tumors caused by a germline KIT gene mutation (p.Leu576Pro) |
|
|
|
|
|
|
|
|
|
| Cystic parathyroid glands in MEN1: A rare entity? |
|
|
|
|
|
|
|
|
|
| Genetically diagnosed Birt–Hogg–Dubé syndrome and familial cerebral cavernous malformations in the same individual: a case report |
|
|
|
|
|
|
|
|
|
| TP53 and CDKN1A mutation analysis in families with Li–Fraumeni and Li–Fraumeni like syndromes |
|
|
|
|
|
|
|
|
|
| Expanding the genotype–phenotype spectrum in hereditary colorectal cancer by gene panel testing |
|
|
|
|
|
|
|
|
|
| Exploring clinicians’ attitudes about using aspirin for risk reduction in people with Lynch Syndrome with no personal diagnosis of colorectal cancer |
|
|
|
|
|
|
|
|
|
| Pancreas-sparing total duodenectomy for Spigelman stage IV duodenal polyposis associated with familial adenomatous polyposis: experience of 10 cases at a single institution |
|
|
|
|
|
|
|
|
|
| Factors associated with cancer worries in individuals participating in annual pancreatic cancer surveillance |
|
|
|
|
|
|
|
|
|
| Hereditary breast and ovarian cancer: successful systematic implementation of a group approach to genetic counselling |
|
|
|
|
|
|
|
|
|
| Mutational analysis of TP53 gene in Tunisian familial hematological malignancies and sporadic acute leukemia cases |
|
|
|
|
|
|
|
|
|
| Association of monoallelic MUTYH mutation among Egyptian patients with colorectal cancer |
|
|
|
|
|
|
|
|
|
| Frequency of germline PALB2 mutations among women with epithelial ovarian cancer |
|
|
|
|
|
|
|
|
|
| Performance of Lynch syndrome predictive models in quantifying the likelihood of germline mutations in patients with abnormal MLH1 immunoexpression |
|
|
|
|
|
|
|
|
|
| BRCA testing within the Department of Veterans Affairs: concordance with clinical practice guidelines |
|
|
|
|
|
|
|
|
|
| Calculating the optimal surveillance for head and neck paraganglioma in SDHB-mutation carriers |
|
|
|
|
|
|
|
|
|
| A novel germline POLE mutation causes an early onset cancer prone syndrome mimicking constitutional mismatch repair deficiency |
|
|
|
|
|
|
|
|
|
| Hereditary leiomyomatosis and renal cell cancer syndrome: identification and clinical characterization of a novel mutation in the FH gene in a Colombian family |
|
|
|
|
|
|
|
|
|
| Nevoid basal cell carcinoma syndrome caused by splicing mutations in the PTCH1 gene |
|
|
|
|
|
|
|
|
|
| Do women change their breast cancer mammogram screening behaviour after BRCA1/2 testing? |
|
|
|
|
|
|
|
|
|
| Characterization of BRCA1 and BRCA2 variants found in a Norwegian breast or ovarian cancer cohort |
|
|
|
|
|
|
|
|
|
| Community attitudes towards a Jewish community BRCA1/2 testing program |
|
|
|
|
|
|
|
|
|
| First description of mutational analysis of MLH1, MSH2 and MSH6 in Algerian families with suspected Lynch syndrome |
|
|
|
|
|
|
|
|
|
| Dilemmas in the management of screen-detected lesions in patients at high risk for pancreatic cancer |
|
|
|
|
|
|
|
|
|
| Multi-gene panel testing for hereditary cancer susceptibility in a rural Familial Cancer Program |
|
|
|
|
|
|
|
|
|
| Undefined familial colorectal cancer and the role of pleiotropism in cancer susceptibility genes |
|
|
|
|
|
|
|
|
|
| A model for patient-direct screening and referral for familial cancer risk |
|
|
|
|
|
|
|
|
|
| Occurrence of renal cell carcinoma and hematologic malignancies (predominantly lymphoid) in individuals and in families |
|
|
|
|
|
|
|
|
|
| An investigation of the factors effecting high-risk individuals’ decision-making about prophylactic total gastrectomy and surveillance for hereditary diffuse gastric cancer (HDGC) |
|
|
|
|
|
|
|
|
|
| Introduction to special issue of Familial Cancer |
|
|
|
|
|
|
|
|
|
| Surgical considerations in FAP-related pouch surgery: Could we do better? |
|
|
|
|
|
|
|
|
|
| Angelina and Brad effect |
|
|
|
|
|
|
|
|
|
| Increased incidence of bladder cancer, lymphoid leukaemia, and myeloma in a cohort of Queensland melanoma families |
|
|
|
|
|
|
|
|
|
| Chemoprevention of familial adenomatous polyposis |
|
|
|
|
|
|
|
|
|
| Ventricular fibrillation resulting from electrolyte imbalance reveals vipoma in MEN1 syndrome |
|
|
|
|
|
|
|
|
|
| Familial adenomatous polyposis in pediatrics: natural history, emerging surveillance and management protocols, chemopreventive strategies, and areas of ongoing debate |
|
|
|
|
|
|
|
|
|
| Recent discoveries in the molecular genetics of Lynch syndrome |
|
|
|
|
|
|
|
|
|
| MSI detection and its pitfalls in CMMRD syndrome in a family with a bi-allelic MLH1 mutation |
|
|
|
|
|
|
|
|
|
| Identification of a novel PMS2 alteration c.505C>G (R169G) in trans with a PMS2 pathogenic mutation in a patient with constitutional mismatch repair deficiency |
|
|
|
|
|
|
|
|
|
| Lynch syndrome in South America: past, present and future |
|
|
|
|
|
|
|
|
|
| Hereditary cancer registries improve the care of patients with a genetic predisposition to cancer: contributions from the Dutch Lynch syndrome registry |
|
|
|
|
|
|
|
|
|
| Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer |
|
|
|
|
|
|
|
|
|
| Genetic counseling and cascade genetic testing in Lynch syndrome |
|
|
|
|
|
|
|
|
|
| CTNNB1-mutant colorectal carcinomas with immediate invasive growth: a model of interval cancers in Lynch syndrome |
|
|
|
|
|
|
|
|
|
| Estimating cumulative risks for breast cancer for carriers of variants in uncommon genes |
|
|
|
|
|
|
|
|
|
| Evaluation of TP53 Pro72Arg and MDM2 SNP285–SNP309 polymorphisms in an Italian cohort of LFS suggestive patients lacking identifiable TP53 germline mutations |
|
|
|
|
|
|
|
|
|
| No evidence of increased breast cancer risk for proven noncarriers from BRCA1 and BRCA2 families |
|
|
|
|
|
|
|
|
|
| Decentralized colonoscopic surveillance with high patient compliance prevents hereditary and familial colorectal cancer |
|
|
|
|
|
|
|
|
|
| Evolution of cancer risk assessment and counseling related to psychological, financial and legal implications |
|
|
|
|
|
|
|
|
|
| Difference in CXCR4 expression between sporadic and VHL-related hemangioblastoma |
|
|
|
|
|
|
|
|
|
| MEN 2A-related cutaneous lichen amyloidosis: report of three kindred and systematic literature review of clinical, biochemical and molecular characteristics |
|
|
|
|
|
|
|
|
|
| Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India |
|
|
|
|
|
|
|
|
|
| Communicating genetic test results within the family: Is it lost in translation? A survey of relatives in the randomized six-step study |
|
|
|
|
|
|
|
|
|
| Colonoscopy and chromoscopy in hereditary colorectal cancer syndromes |
|
|
|
|
|
|
|
|
|
| Familial atypical multiple mole melanoma (FAMMM) syndrome: history, genetics, and heterogeneity |
|
|
|
|
|
|
|
|
|
| High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine |
|
|
|
|
|
|
|
|
|
| Müllerian intra-abdominal carcinomatosis in hereditary breast ovarian cancer syndrome: implications for risk-reducing surgery |
|
|
|
|
|
|
|
|
|
| Finding the needle in a haystack: identification of cases of Lynch syndrome with MLH1 epimutation |
|
|
|
|
|
|
|
|
|
| Colorectal cancer risk variants at 8q23.3 and 11q23.1 are associated with disease phenotype in APC mutation carriers |
|
|
|
|
|
|
|
|
|
| Evaluation of laboratory perspectives on hereditary cancer panels |
|
|
|
|
|
|
|
|
|
| Controversies in the surgery of patients with familial adenomatous polyposis and Lynch syndrome |
|
|
|
|
|
|
|
|
|
| Update on Lynch syndrome genomics |
|
|
|
|
|
|
|
|
|
| Hereditary cancer syndromes: utilizing DNA repair deficiency as therapeutic target |
|
|
|
|
|
|
|
|
|
| Modeling the dyadic effects of parenting, stress, and coping on parent–child communication in families tested for hereditary breast-ovarian cancer risk |
|
|
|
|
|
|
|
|
|
| Rapid detection of germline mutations for hereditary gastrointestinal polyposis/cancers using HaloPlex target enrichment and high-throughput sequencing technologies |
|
|
|
|
|
|
|
|
|
| A mutation of the succinate dehydrogenase B gene in a Korean family with paraganglioma |
|
|
|
|
|
|
|
|
|
| BRCA1/BRCA2 founder mutations and cancer risks: impact in the western Danish population |
|
|
|
|
|
|
|
|
|
| Migrant breast cancer patients and their participation in genetic counseling: results from a registry-based study |
|
|
|
|
|
|
|
|
|
| Ovarian cancer patients at high risk of BRCA mutation: the constitutional genetic characterization does not change prognosis |
|
|
|
|
|
|
|
|
|
| Exome sequencing identifies potential novel candidate genes in patients with unexplained colorectal adenomatous polyposis |
|
|
|
|
|
|
|
|
|
| Constitutional MLH1 methylation presenting with colonic polyposis syndrome and not Lynch syndrome |
|
|
|
|
|
|
|
|
|
| CDH1 germline mutations and hereditary lobular breast cancer |
|
|
|
|
|
|
|
|
|
| The impact of an interventional counselling procedure in families with a BRCA1/2 gene mutation: efficacy and safety |
|
|
|
|
|
|
|
|
|
| Germline BAP1 mutations misreported as somatic based on tumor-only testing |
|
|
|
|
|
|
|
|
|
| Developing and assessing the utility of a You-Tube based clinical genetics video channel for families affected by inherited tumours |
|
|
|
|
|
|
|
|
|
| Relationship of immunohistochemistry, copy number aberrations and epigenetic disorders with BRCAness pattern in hereditary and sporadic breast cancer |
|
|
|
|
|
|
|
|
|